BACKGROUND
Texcell is a service company offering GLP- and GMP-compliant viral safety testing and immunology services.
With over 20 years of experience in the performance of biosafety and viral validation tests, Texcell has evaluated a large number of products – including some that have received marketing approval from the FDA, the EMEA and the MHW.
The company’s expertise is acknowledged worldwide and (since 2006) and it has developed commercial relationships with representatives based in Japan, India and South Korea. In 2010, Texcell has taken the majority in a company based in Middletown (Maryland) renamed Texcell North America.
DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY
Texcell offers a full catalogue of assays for the characterization of cell banks, the batch release of cellderived biotechnological products and viral validation studies for evaluating the ability of industrial process steps to eliminate and/or inactivate viruses (over 30 relevant or model viruses are available) and prions.
Texcell acts both as a contract service organization (CSO) and a central lab for preclinical and clinical trials. Texcell offers an immunology-dedicated technology platform with an exhaustive range of GLP assay development services (optimization and validation) for analyzing the immune response to humoral and/or cell-based mediation.
Today’s compound development timelines have to be as short as possible. Viral safety testing, viral validation studies and clinical studies must be continually improved, in order to optimize the therapeutic strategy. The company acts as a true partner for its customers and the staff is committed to offering the right experimental protocols and tools.
